Xaliproden in amyotrophic lateral sclerosis: early clinical trials.

MLA

Lacomblez, Lucette, et al. “Xaliproden in Amyotrophic Lateral Sclerosis: Early Clinical Trials.” Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders, vol. 5, no. 2, June 2004, pp. 99–106. EBSCOhost, https://doi.org/10.1080/14660820410018973.

APA

Lacomblez, L., Bensimon, G., Douillet, P., Doppler, V., Salachas, F., & Meininger, V. (2004). Xaliproden in amyotrophic lateral sclerosis: early clinical trials. Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders, 5(2), 99–106. https://doi.org/10.1080/14660820410018973

Chicago

Lacomblez, Lucette, Gilbert Bensimon, Patrice Douillet, Valérie Doppler, Francois Salachas, and Vincent Meininger. 2004. “Xaliproden in Amyotrophic Lateral Sclerosis: Early Clinical Trials.” Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders 5 (2): 99–106. doi:10.1080/14660820410018973.